Видео с ютуба Biogen Apellis Acquisition

Emergency Pod: Biogen to Acquire Apellis

Biogen and Apellis: Biotech Acquisition Market Dynamics

Biogen Conference Call on Acquisition of Apellis | March 31, 2026

Biogen’s $5.6 Billion Apellis Deal: Why Rare Disease Is the New Biotech M&A Battleground

Apellis Stock EXPLODES 135% – Biogen Deal Explained

Информация об акциях BIIB: Сделка Biogen с Apellis на сумму 5,6 млрд долларов — покупать или прод...

Biogen to Buy Apellis; Nvidia Invests $2 Billion in Marvell | Stock Movers

Biogen купит Apellis; Lilly купит производителя снотворных препаратов; Nvidia инвестирует 2 милли...

Информация о приобретении акций APLS: подробности сделки с Biogen и выкупа за 41 доллар.

Biogen CEO Chris Viehbacher on 2026 drug pipeline outlook, rare disease strategy

Biogen's $5.6B Buyout Sends Apellis Stock Up 138%!

Biogen reopens following FDA approval of company's Alzheimer drug

Компания Lilly купит Centessa Pharmaceuticals; Biogen купит Apellis; Unilever Foods выходит из би...

Генеральный директор Biogen об одобрении FDA препарата от болезни Альцгеймера

Biogen's $5.6B Apellis Buyout and McCormick's Massive Unilever Flavor Merger

Sharp Says Biogen Idec Can Grow Alone or Be Acquired: Video

The $42B Samsung Biogen deal is too cheap: Oppenheimer Health Care analyst

McCormick's $45 Billion Bite of Unilever and Biogen's Apellis Buyout

Biogen's $5.6B Rare Disease Grab & McCormick's $20B Flavor Merger